# A new C-peptide minimal model to assess β-cell responsiveness to glucagon in individuals with and without type 2 diabetes.

> PubMed lists PMID 39925097 in American journal of physiology. Endocrinology and metabolism as Journal Article, with publication-date metadata of 2025-02-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39925097-glucagon:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-13
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39925097-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39925097-glucagon-v1.json
- Content SHA-256: `5fb29b56bb51ad35e5bcc9d8fde6ca69a68c27f93b02a7a8263b3daf73bcc8f8`

## Claims and source pins

### Headline

A new C-peptide minimal model to assess β-cell responsiveness to glucagon in individuals with and without type 2 diabetes. ([`pubmed-observation-pmid-39925097-2026-08-13-fd804ff59be9`](#source-pubmed-observation-pmid-39925097-2026-08-13-fd804ff59be9))

### Summary

PubMed lists PMID 39925097 in American journal of physiology. Endocrinology and metabolism as Journal Article, with publication-date metadata of 2025-02-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39925097-2026-08-13-fd804ff59be9`](#source-pubmed-observation-pmid-39925097-2026-08-13-fd804ff59be9))

### Paragraph 1

PubMed lists PMID 39925097 in American journal of physiology. Endocrinology and metabolism as Journal Article, with publication-date metadata of 2025-02-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39925097-2026-08-13-fd804ff59be9`](#source-pubmed-observation-pmid-39925097-2026-08-13-fd804ff59be9))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39925097-2026-08-13-fd804ff59be9`](#source-pubmed-observation-pmid-39925097-2026-08-13-fd804ff59be9))

## Sources

<a id="source-pubmed-observation-pmid-39925097-2026-08-13-fd804ff59be9"></a>
- **A new C-peptide minimal model to assess β-cell responsiveness to glucagon in individuals with and without type 2 diabetes. · retained source version 1:2026-08-13:current:fd804ff59be9f87afdd580e361a4a46c7a5568fb21223cdb9906f2f1a2ad78e4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39925097/) (`pubmed-observation-pmid-39925097-2026-08-13-fd804ff59be9`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "A new C-peptide minimal model to assess β-cell responsiveness to glucagon in individuals with and without type 2 diabetes." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39925097-glucagon-v1.json SHA-256: 5fb29b56bb51ad35e5bcc9d8fde6ca69a68c27f93b02a7a8263b3daf73bcc8f8.